XML 28 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Follow-On Offering
ATM
Common Stock
Common Stock
Follow-On Offering
Common Stock
ATM
Additional Paid-in Capital
Additional Paid-in Capital
Follow-On Offering
Additional Paid-in Capital
ATM
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2023 $ 225,848,000           $ 512,617,000     $ (287,308,000) $ 539,000
Beginning Balance, Shares at Dec. 31, 2023       49,350,788              
Stock-based compensation expense 11,722,000           11,722,000        
Employee Stock Purchase Plan Issuance 177,000           177,000        
Employee Stock Purchase Plan Issuance, Shares       24,477              
Vesting of restricted stock, Shares       310,245              
Stock options exercises 1,418,000           1,418,000        
Stock options exercises, Shares       312,769              
Unrealized gain (loss) on marketable securities (271,000)                   (271,000)
Currency translation adjustment (5,000)                    
Other (5,000)                   (5,000)
Net loss (86,919,000)                 (86,919,000)  
Ending Balance at Dec. 31, 2024 151,970,000           525,934,000     (374,227,000) 263,000
Ending Balance, Shares at Dec. 31, 2024       49,998,279              
Stock-based compensation expense 14,317,000           14,317,000        
Employee Stock Purchase Plan Issuance 164,000           164,000        
Employee Stock Purchase Plan Issuance, Shares       28,125              
Vesting of restricted stock, Shares       532,401              
Stock options exercises 1,010,000           1,010,000        
Stock options exercises, Shares       238,045              
Unrealized gain (loss) on marketable securities (179,000)                   (179,000)
Issuance of common stock   $ 46,517,000 $ 6,054,000         $ 46,517,000 $ 6,054,000    
Issuance of common stock, Shares         11,735,565 1,055,362          
Issuance of pre-funded warrants   14,156,000           14,156,000      
Issuance of common stock warrants   $ 9,254,000           $ 9,254,000      
Currency translation adjustment (186,000)                   (186,000)
Other 27,000           27,000        
Net loss (106,191,000)                 (106,191,000)  
Ending Balance at Dec. 31, 2025 $ 136,913,000           $ 617,433,000     $ (480,418,000) $ 102,000
Ending Balance, Shares at Dec. 31, 2025       63,587,777